GLS and neoplasm: reported that KRAS-driven lung tumors require pyruvate carboxylase and pyruvate dehydrogenase, and are less dependent on glutaminase than cultured cells (139), suggesting a crucial impact of tumor microenvironment in glutamine metabolism and glutaminase inhibition.